Sansure Biotech Inc. (688289.SS) — Stock Score Summary

Sansure Biotech Inc. (688289.SS) has a MoatMap StockRank of 31/100 based on Quality (43/100), Value (38/100), and Momentum (38/100) factor scores. The current signal is SELL. Sansure Biotech is an in vitro diagnostics company. It does not operate as a CDMO and therefore misses our CDMO pricing power theme, while post-pandemic demand normalization continues to weigh on its core business.

Sansure Biotech is a leading in-vitro diagnostics (IVD) company specializing in molecular diagnostic reagents and instruments, particularly PCR-based testing. The company's competitive moat is built on its proprietary "one-tube" fast extraction technology and a highly automated, high-throughput testing platform. It is a dominant market leader in China's molecular diagnostics sector, with a rapidly expanding global distribution network.

Key Financial Metrics

Price$2.12
Market Cap$1.4B
P/E (TTM)59.42
P/E (Forward)19.56
Price/Book1.24
Return on Equity2.7%
Return on Invested Capital2.4%
Debt/Equity15.27
Gross Margin100.0%
Operating Margin14.0%
Revenue Growth-5.0%
Dividend Yield3.1%

Sansure Biotech Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sansure Biotech Inc.’s (688289.SS) StockRank?
MoatMap’s StockRank for Sansure Biotech Inc. (688289.SS) is 31/100, with a Sell signal. It is a composite of Quality (43), Value (38), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sansure Biotech Inc. have an economic moat?
Sansure Biotech Inc. (688289.SS) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sansure Biotech Inc. a buy, hold, or sell?
MoatMap’s current signal for Sansure Biotech Inc. (688289.SS) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sansure Biotech Inc. in?
Sansure Biotech Inc. (688289.SS) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (China).
Browse all ranked stocks688289.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock